Parties Exchange Briefing on Admissibility of MM-Related Testimony

NEW ORLEANS -- Parties in a Louisiana benzene case continue to dispute the admissibility of plaintiff experts, with the defendants recently reasserting their position that there is no admissible science linking benzene exposure to the development of multiple myeloma. Cole, et al. v. Ashland Inc., et al., No. 09-6584 (E.D. La.).

Ashland Inc.'s Oct. 15 motion filed in the U.S. District Court for the Eastern District of Louisiana specifically takes issue with any causation opinions that opine that benzene is associated with the plaintiff's diagnosis of monoclonal gammopathy of undetermined significance ('MGUS') or a future risk of contracting multiple myeloma …